The ACR is pleased to welcome new and returning leaders to the ACR board of directors and ARHP executive committee who were appointed in November. The following members were selected to serve as the newest members-at-large of the ACR board of directors. Each of them shared what they will bring to the table.
A Review of Wegener’s Treatment Data
Clinical trials show changing role of existing treatment and introduction of newer medications
Drug UPDATES
Information on New Approvals and Medication Safety
Shingles, Chickenpox Hospitalizations Higher for Patients on Anti-TNF Drugs
More research needed to clarify risks and benefits of VZV vaccination
Can Technology Help Solve Scleroderma Renal Crisis?
A case study in using the Internet to facilitate rare disease research
ACR Honors Accomplishments in Rheumatology
Rheumatologists and health professionals recognized for their contributions to the field
“A Common Language for Spondyloarthritis”
ASAS fills a niche, changes dogma with consensus approach
For Myopathy Basic Diagnostic Rules Hold
Rare and challenging, idiopathic inflammatory myopathies are gaining from collaborative research
Research Tracks Possible Benefit of Src-like Adaptor Protein
A study recently submitted for publication has demonstrated that manipulating T-cell receptor complex–mediated signaling can prevent the development of autoimmune arthritis in mice and may lead to new human therapies without the drawbacks associated with existing treatments.
Quadruple-threat Rheumatologist
In Norway and on the international front, Tore Kvien, MD, PhD, has propelled clinical research to new levels
- « Previous Page
- 1
- …
- 63
- 64
- 65
- 66
- 67
- …
- 77
- Next Page »